Trials / Completed
CompletedNCT01853306
A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Oral Bioavailability of Veliparib Extended Release Formulations in Subjects With Solid Tumors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 71 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This is a 3 part phase 1 study to evaluate the safety, pharmacokinetic and oral bioavailability of veliparib in subjects with solid tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Veliparib | veliparib |
Timeline
- Start date
- 2013-03-18
- Primary completion
- 2017-05-03
- Completion
- 2017-06-29
- First posted
- 2013-05-15
- Last updated
- 2017-11-21
Source: ClinicalTrials.gov record NCT01853306. Inclusion in this directory is not an endorsement.